Edgewise Therapeutics Cash Flow Statement (2020-2026) | EWTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-12.95M	-12.84M	-17.96M	-16.52M	-18.20M	-19.85M	-29.93M	-28.49M	-27.01M	-30.20M	-34.90M	-32.56M	-34.13M	-44.26M	-40.80M	-36.12M	-40.67M	-54.02M	-49.01M	-57.33M
Depreciation and Depletion (Quarter)	0.10M	0.11M	0.10M	0.10M	0.10M	0.10M	0.20M	0.40M	0.40M	0.50M	0.47M	0.50M	0.50M	0.57M	0.51M	0.50M	0.50M	0.48M	0.54M	0.50M
Share-based Compensation (Quarter)	1.55M	1.87M	1.98M	2.04M	3.17M	3.74M	3.84M	0.03M	4.56M	-11.30M	4.87M	1.58M	6.88M	7.74M	9.06M	7.73M	8.09M	-17.07M	8.71M	9.36M
Cash from Operations (Quarter)	-8.26M	-9.42M	-12.57M	-16.25M	-11.96M	-11.86M	-22.83M	-20.23M	-22.06M	-26.83M	-28.60M	-26.10M	-27.37M	-26.96M	-37.87M	-32.58M	-34.78M	-38.59M	-42.54M	-42.47M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)			-0.67M	0.77M	0.07M	0.38M	2.08M	-1.99M	0.05M	9.39M	3.15M	3.55M	-6.53M	0.05M	0.04M	4.08M	2.06M	1.48M	1.01M	0.81M
Depreciation & Amortization (CF) (Quarter)	0.10M	0.11M	0.10M	0.10M	0.10M	0.10M	0.20M	0.40M	0.40M	0.50M	0.47M	0.50M	0.50M	0.57M	0.51M	0.50M	0.50M	0.48M	0.54M	0.50M
Change in Working Capital
Change in Account Payables (Quarter)	-0.52M	1.55M	1.19M	-2.65M	0.94M	0.58M	-0.16M	-0.31M	1.76M	-1.38M	0.78M	1.89M	-1.03M	0.09M	2.86M	-0.15M	-2.13M	-0.30M	1.45M	0.78M
Change in Accured Expenses (Quarter)	-0.56M	0.77M	-1.45M	1.69M	-0.34M	1.33M	-1.96M	2.90M	-0.57M	1.29M	-2.77M	1.32M	1.51M	1.10M	0.12M	-1.42M	0.55M	1.44M	0.64M	2.90M
Other Working Capital Changes (Quarter)			0.02M	0.04M	1.08M	1.78M	0.12M		-0.10M	-0.12M	-0.16M	-0.17M	-0.18M	0.29M	-0.18M	-0.19M	-0.19M	-0.19M	-0.20M	-0.20M
Investing Activities
Capital Expenditures (Quarter)	0.45M	0.08M	0.31M	0.61M	1.33M	0.26M	4.37M	0.76M	0.46M	0.16M	0.14M	-0.03M	0.92M	-0.99M	0.04M	0.03M	-0.03M	0.15M	0.04M	0.03M
Change in Acquisitions & Divestments (Quarter)	10.20M	25.80M	36.88M	59.77M	30.28M	69.86M	69.76M	114.12M	94.50M	-258.26M	58.71M	77.67M	-123.66M	3.07M	15.00M	214.12M	-177.67M	15.93M	3.97M	108.81M
Cash from Investing Activities (Quarter)	-31.61M	14.12M	31.39M	-0.05M	-26.32M	-75.60M	49.04M	3.44M	23.42M	26.98M	-268.31M	37.37M	25.36M	20.92M	43.90M	-162.17M	35.72M	49.76M	2.43M	78.49M
Financing Activities
Other financing activities (Quarter)	-186.08M	0.18M	0.07M	0.26M	0.05M	-0.06M	0.02M	0.03M	0.00M	0.06M	1.93M	1.58M	-3.08M	0.47M	2.26M	-1.66M	3.56M	3.65M	12.17M	2.29M
Change in Capital Stock
Shares Issued (Quarter)	1.53M	7.59M	5.04M	5.06M	1.53M	10.64M	5.04M	5.04M	1.22M	14.49M	1.53M	5.04M	1.46M	15.42M	1.01M	2.00M	1.25M	1.15M	1.01M	7.83M
Net Equity Issued and Repurchased (Quarter)						-0.56M					239.15M					0.26M
Misc.
Cash from Financing Activities (Quarter)	0.04M	0.29M	0.07M	0.18M	129.69M	-0.30M	0.02M	0.37M	-0.21M	52.99M	241.07M	1.95M	3.33M	2.90M	2.22M	188.23M	1.66M	3.98M	12.17M	3.09M
Change in Cash (Quarter)	-39.83M	5.00M	18.89M	-16.11M	91.41M	-87.75M	26.24M	-16.42M	1.15M	53.14M	-55.83M	13.22M	1.32M	-3.14M	8.26M	-6.52M	2.60M	15.14M	-27.94M	39.11M
Free Cash Flow (Quarter)	-8.71M	-9.50M	-12.88M	-16.86M	-13.29M	-12.11M	-27.19M	-20.99M	-22.52M	-26.99M	-28.74M	-26.07M	-28.30M	-25.96M	-37.91M	-32.62M	-34.74M	-38.74M	-42.58M	-42.50M
Net Cash Flow (Quarter)	-39.83M	5.00M	18.89M	-16.11M	91.41M	-87.75M	26.24M	-16.42M	1.15M	53.14M	-55.83M	13.22M	1.32M	-3.14M	8.26M	-6.52M	2.60M	15.14M	-27.94M	39.11M

Research Tools

Datasets

Plans

Developers

Edgewise Therapeutics Cash Flow Statement (2020-2026) | EWTX

Research Tools

Datasets

Plans

Developers

Edgewise Therapeutics Cash Flow Statement (2020-2026) | EWTX

Create an account

Sign In

Reset Password